Pain Relief Is Exceptionally Important In All Cases Of Otitis Externa And Should Be A Priority Alongside Treatment For Clinical Resolution, Urges Leading Expert Sue Paterson
Leading veterinary dermatologist Sue Paterson has raised concerns that vets are not prioritising pain relief in otitis externa (OE) cases, which is having a “profound effect on the quality of life of both dogs and clients”.
As part of a series of new videos commissioned by Elanco Animal Health for Osurnia™ Gel, Sue Paterson has urged vets to think about the impact that pain has on both the dog and owner in cases of otitis externa. The primary concern for many vets is to fight the pathogens to achieve a clinical cure, meaning pain relief can often become a secondary issue. While selection of an appropriate antibiotic is key, it is also important to consider the need for pain relief.
RCVS and European Specialist in Veterinary Dermatology and Senior Vice President of the European Society of Dermatology, Sue Paterson said: “Otitis externa is painful, it’s debilitating, and the degree of discomfort is often underestimated by both the veterinary surgeon and by the client.”
Sue also stated that vets should not underestimate the owner’s concern about pain in their dog. Owners recognise the clinical signs associated with the pain of OE and determine treatment success by their dog recovering from these distressing symptoms.
To help manage the pain associated with OE, Sue recommends a multi-modal approach: ‘’In addition to systemic pain relief, which is really important, a potent topical steroid is really useful to reduce the inflammation inside that dog’s ear, and make it much more comfortable.’’
Betamethasone, the steroid found in Osurnia Gel, is an effective anti-inflammatory that helps to improve comfort for the entire 28-day treatment period.
Sue also calls attention to OE treatments which are able to coat the ear canal and stay there long enough to treat the pathogens and provide sustained pain relief. Osurnia’s gel formulation enters the ear in liquid form which then spreads along the ear canal as a gel.
Specifically speaking about Osurnia, Sue said: “When you put it into the ear, Osurnia Gel coats the lining of the external ear canal which gives prolonged contact with the lining of the canal to help treat the pathogens inside that dog’s ear.”
But despite Osurnia entering the market two years ago, some vets are still saving it for difficult cases. Sue urged vets to re-evaluate their prescribing habits: “Too many vets use this (Osurnia) as a second-line drug and it should be used as a first-line product on the first occasion the dog comes through the door.”
* For the treatment of acute otitis externa and acute exacerbation of recurrent otitis externa associated
with Staphylococcus pseudintermedius and Malassezia pachydermatis. Osurnia ear gel for dogs
contains terbinafine, florfenicol and betamethasone acetate.
For additional comment, images, or requests for interviews, please contact:
+44 1273 712146 (direct)
Elanco is a global innovation-driven company that develops and markets products to improve animal health, food animal production and companion animal care in nearly 70 countries. Elanco, a division of leading pharmaceutical company Eli Lilly and Company, employs approximately 7,000 people worldwide, with offices in more than 40 countries. Additional information about Elanco is available at www.elanco.com.
Further product information is also available from the Summary of Product Characteristics (SPC) available at www.vmd.defra.gov.uk/ProductInformationDatabase/
Osurnia ear gel for dogs contains terbinafine, florfenicol and betamethasone acetate. Legal category POM-V UK, POM IE. Information regarding the side effects, precautions, warnings and contra-indications can be found in product packaging and leaflets; further information can also be found in the Summary of Product Characteristics. Advice should be sought from the medicine prescriber.
For further information call Elanco Animal Health (the animal health division of Eli Lilly and Company Limited) on +44 (0)1256 353131 or write to Elanco Animal Health, Lilly House, Priestley Road, Basingstoke, Hampshire RG24 9NL, UK.Use medicines responsibly www.noah.co.uk/responsible. Osurnia, Elanco and the Diagonal Bar logo are trademarks of Elanco or its affiliates.
More from Elanco
- Elanco launches dedicated digital resource hub to help vets treat canine otitis externa
- Elanco launches online social media tutorials in response to vet demand
- Elanco and Onsior launch online an in-practice campaign to help ease the discomfort of canine osteoarthritis
- Onsior (6 mg tablets) receives new indication to treat pain and inflammation in cats with chronic musculoskeletal disease
- Get hands-on and tailor language to engage dog owners in canine osteoarthritis (OA) cases to help take the pain out of consults, encourages RCVS Specialist